Echo Therapeutics, Inc. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2011-12-27: Form 8-K; Period of report 2011-12-20; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
- 2011-12-06: Form 8-K; Period of report 2011-12-05; Description 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events; Details 1.01.
- 2011-11-18: Form 8-K; Period of report 2011-11-14; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
- 2011-11-08: Form 8-K; Period of report 2011-11-08; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2011-12-27 | 8-K | 2011-12-20 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | echo8kdec272011.htm |
| 2011-12-06 | 8-K | 2011-12-05 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 On December 5, 2011, Echo Therapeutics, Inc. (the "Company") entered into purchase agreements with certain strategic investors relating to the issuance and sale of an aggregate of 2,398,344 shares of the Company's common stock, par value $0.01, and warrants to purchase an aggregate of 959,580 shares of the Company's common stock. 8.01 On December 6, 2011, the Company issued a press release announcing the offering described in Item 1.01. | echo8kdec62011.htm |
| 2011-11-18 | 8-K | 2011-11-14 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | echo8knov182011.htm |
| 2011-11-08 | 8-K | 2011-11-08 | 2.02 Results of Operations and Financial Condition | 2.02 On November 8, 2011, Echo Therapeutics, Inc. (the “Company”) issued a press release announcing its financial results for the quarter and nine months ended September 30, 2011. | echo8knov82011.htm |
| 2011-11-01 | 8-K | 2011-10-27 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 3.02 The Company refers to Item 1.01 above, Entry into a Material Definitive Agreement, and incorporates by reference the contents of that section herein, as if fully set forth under this Section 3.02. 8.01 · on an as adjusted basis to reflect the Exchange described in Item 1.01. | echo8knov12011.htm |
| 2011-08-16 | 8-K | 2011-08-12 | 2.02 Results of Operations and Financial Condition | 2.02 On August 12, 2011, Echo Therapeutics, Inc. (the “Company”) issued a press release announcing its results of operations for the quarter ended June 30, 2011. | form8-k.htm |
| 2011-07-18 | 8-K | 2011-07-13 | 5.07 Submission of Matters to a Vote of Security Holders | form8k-07182011_020717.htm | |
| 2011-06-30 | 8-K | 2011-06-28 | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | 3.01 On June 28, 2011, Echo Therapeutics, Inc. (the "Company") issued a press release (the "Press Release") announcing that its common stock has been cleared for listing on NASDAQ. | form8k-06302011_010641.htm |
| 2011-06-15 | 8-K | 2011-06-13 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Harry Mitchell, the Company's Chief Operating Officer, resigned from the Company effective as of June 13, 2011. | form8k-06152011_010606.htm |
| 2011-05-20 | 8-K | 2011-05-16 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On May 16, 2011, the Board of Directors appointed Christopher P. Schnittker as Chief Financial Officer and Treasurer of the Company effective immediately. | form8k-05202011_010517.htm |
| 2011-03-23 | 8-K | 2011-03-17 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | form8-k.htm |
| 2011-02-14 | 8-K | 2011-02-08 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 1.01 Entry into a Material Definitive Agreement. 2.03 The information set forth in Item 1.01 is incorporated by reference into this Item 2.03. 3.02 The information set forth under Item 1.01 is incorporated by reference into this Item 3.02. 5.02 On February 8, 2011, the Board of Directors of the Company (the “Board”) appointed William F. Grieco and James F. Smith to fill vacancies on the Board. 5.03 The information set forth under Item 1.01 is incorporated by reference into this Item 5.03. | form8-k.htm |
| 2011-01-11 | 8-K | 2011-01-05 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 Entry into a Material Definitive Agreement. 2.03 The information set forth in Item 1.01 is incorporated by reference into this Item 2.03. 5.02 On January 10, 2011, Walter W. Witoshkin., a member of the Company’s Board of Directors, resigned from his position as a Director due to family obligations. | form8k-20110105.htm |
| 2011-01-05 | 8-K | 2010-12-29 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities | 1.01 Entry into a Material Definitive Agreement. 2.03 The information set forth in Item 1.01 is incorporated by reference into this Item 2.03. 3.02 The information set forth under Item 1.01 is incorporated by reference into this Item 3.02. | form8-k.htm |